Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

Two women lost hair after mesotherapy for hair loss, with one having permanent and the other temporary hair loss.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

CTE and FPHL are different hair loss types with unique causes.

Washing test helps identify hair loss type, low iron levels significant.

Minoxidil can help grow hair and make hair follicles bigger, but it can also cause side effects.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Scalp biopsies are essential for accurately diagnosing alopecia areata.

Hair mesotherapy might help with certain types of hair loss but lacks strong scientific proof and has some risks.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Mesotherapy is more effective than topical spray for female hair loss treatment.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Horizontal scalp biopsy sections effectively diagnose and predict MPAA, with follicular density and inflammation impacting hair regrowth.

Understanding hair follicle structure is key for treating hair disorders and could help develop new treatments.

Mesotherapy for hair loss lacks evidence of effectiveness and safety and should not be used without further scientific support.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.